Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells (Q39702537)

14 September 2017

Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells (English)

1 reference

14 September 2017

Patricia Zancan

1

1 reference

14 September 2017

Mauro Sola-Penna

series ordinal

2

1 reference

14 September 2017

Cristiane Marques Furtado

series ordinal

3

1 reference

14 September 2017

Daniel Da Silva

series ordinal

4

1 reference

14 September 2017

18 April 2010

1 reference

Molecular Genetics and Metabolism

14 September 2017

1 reference

14 September 2017

100

1 reference

14 September 2017

4

1 reference

14 September 2017

372-378

1 reference

Regulation of the Warburg effect in early-passage breast cancer cells.

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Cancer metabolism: facts, fantasy, and fiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Targeting of cancer energy metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Lactate: mirror and motor of tumor malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Metabolic regulation by lactate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Why do cancers have high aerobic glycolysis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Hypoxia, drug therapy and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Serotonin stimulates mouse skeletal muscle 6-phosphofructo-1-kinase through tyrosine-phosphorylation of the enzyme altering its intracellular localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Glycolytic enzyme expression and pyruvate kinase activity in cultured fibroblasts from type 1 diabetic patients with and without nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Tumor cell energy metabolism and its common features with yeast metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Cancer's sweet tooth: the Janus effect of glucose metabolism in tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Cancer's molecular sweet tooth and the Warburg effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Targeting HIF-1 for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Adaptation of energy metabolism in breast cancer brain metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Evolution of the androgen receptor pathway during progression of prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Prognostic significance of erythropoietin expression in human endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Cellular distribution of phosphofructokinase activity and implications to metabolic regulation in human breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Lactate favours the dissociation of skeletal muscle 6-phosphofructo-1-kinase tetramers down-regulating the enzyme and muscle glycolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Calmodulin upregulates skeletal muscle 6-phosphofructo-1-kinase reversing the inhibitory effects of allosteric modulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Calcium influx: a possible role for insulin modulation of intracellular distribution and activity of 6-phosphofructo-1-kinase in human erythrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Regulation of human erythrocyte metabolism by insulin: cellular distribution of 6-phosphofructo-1-kinase and its implication for red blood cell function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Clotrimazole inhibits and modulates heterologous association of the key glycolytic enzyme 6-phosphofructo-1-kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Taxol (paclitaxel) induces a detachment of phosphofructokinase from cytoskeleton of melanoma cells and decreases the levels of glucose 1,6-bisphosphate, fructose 1,6-bisphosphate and ATP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Detachment of the glycolytic enzymes, phosphofructokinase and aldolase, from cytoskeleton of melanoma cells, induced by local anesthetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Multifaceted roles of glycolytic enzymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Phosphorylation of Bad at Thr-201 by JNK1 promotes glycolysis through activation of phosphofructokinase-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Decrease in cytoskeleton-bound phosphofructokinase in muscle induced by high intracellular calcium, serotonin and phospholipase A2 in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Altered allosteric properties of cytoskeleton-bound phosphofructokinase in muscle from mice with X chromosome-linked muscular dystrophy (mdx)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

Tumor Mitochondria and the Bioenergetics of Cancer Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.04.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMGME.2010.04.006

1 reference

14 September 2017

1 reference